News Daily News Meta-Analysis: Mixed Results Seen with First-Gen DES in STEMI Patients March 05, 2012
News Daily News Meta Análisis: Resultados Contradictorios con los SLF de 1ª Generación en Pacientes STEMI March 05, 2012
News Daily News El Estudio PEPCAD-DES: El Balón recubierto de Paclitaxel es mejor que el Balón convencional para resolver la reestenosis de un SLF March 05, 2012
News Daily News Complications of In-Stent Restenosis High, Traditional Risk Factors Absent Yael L. Maxwell February 15, 2012
News Daily News DES Associated with Less Downstream Lesion Development than BMS L.A. McKeown November 04, 2011
News Daily News First DES for Above-the-Knee Vascular Disease on the Horizon L.A. McKeown October 18, 2011
News Daily News Clinical Variables Added to Syntax Score Increases Predictive Ability L.A. McKeown September 30, 2011
News Daily News HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen Leah Lawrence September 29, 2011
News Daily News Drug-Eluting Balloon Continues to Show Positive Results in SFA, Popliteal Disease Jason Kahn September 15, 2011
News Daily News Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES September 14, 2011
News Daily News ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions Jason Kahn September 12, 2011
News Daily News Drug-Eluting Balloons Show ‘Impressive’ Results in Below-the-Knee Lesions Jason Kahn September 08, 2011
News Daily News TRIAS HR Published: Genous Stent Doubles Target Lesion Failure Leah Lawrence August 23, 2011
News Daily News No Apparent Advantage for Everolimus vs. Paclitaxel Stents in Diabetic Patients L.A. McKeown August 19, 2011
News Daily News ESSENCE-DIABETES Published: Xience, Cypher Equally Equipped to Treat Diabetics Caitlin E. Cox August 03, 2011
News Daily News HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics Jason Kahn July 18, 2011
News Daily News DES Show Advantage over BMS for Heart Transplant Complication L.A. McKeown July 01, 2011
News Daily News Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness Caitlin E. Cox June 24, 2011